Rapid detection of beta-lactamase genes in Klebsiella pneumoniae and Escherichia coli from positive blood cultures using nanopore sequencing

ABSTRACT Klebsiella pneumoniae and Escherichia coli are major Enterobacterales pathogens that commonly harbor beta-lactamase enzymes conferring antimicrobial resistance. Conventional antimicrobial susceptibility testing (AST) is time-consuming and may delay appropriate antibiotic treatment, whereas nanopore sequencing enables real-time genetic analysis and may support rapid antimicrobial resistance detection at the point of care. This study evaluated the performance of nanopore sequencing for detecting ceftriaxone and carbapenem resistance in positive blood cultures containing K. pneumoniae or E. coli . In this cross-sectional descriptive study, positive blood culture samples yielding K. pneumoniae or E. coli were analyzed. Bacterial DNA was extracted and sequenced in its native form using the PromethION nanopore platform to detect antimicrobial resistance genes, and sequencing-based predictions were compared with routine blood culture results and standard AST. A total of 62 K. pneumoniae and 96 E. coli samples met the inclusion criteria for DNA extraction and sequencing. Simulated real-time analysis showed that the optimal condition for detecting third-generation cephalosporin and carbapenem resistance genes was approximately 1 h of sequencing, using a sequence divergence threshold of <0.001 against the antimicrobial resistance gene database. For third-generation cephalosporin resistance, sensitivity was 87.0% (95% CI: 79.5%–94.5%) and specificity was 77.8% (95% CI: 68.7%–86.8%); for carbapenem resistance, sensitivity was 77.8% (95% CI: 58.6%–97.0%) and specificity was 96.4% (95% CI: 93.4%–99.5%). Overall, nanopore sequencing is feasible for rapid detection of ceftriaxone and carbapenem resistance directly from positive blood cultures, although further optimization is needed to improve accuracy. IMPORTANCE Bloodstream infections can progress rapidly and require timely selection of effective antimicrobial therapy. However, conventional antimicrobial susceptibility testing typically requires 2–3 days, which may delay optimal treatment. In this study, nanopore sequencing detected key antimicrobial resistance genes in Escherichia coli and Klebsiella pneumoniae directly from positive blood cultures after approximately 1 h of sequencing. This approach could support earlier prediction of antibiotic resistance and help guide more timely treatment decisions for patients with serious infections. The study also identified important limitations, including incorrect predictions for ceftriaxone and carbapenem resistance in some samples. Overall, these findings highlight the potential of rapid DNA sequencing to improve the management of bloodstream infections, while emphasizing that further improvement in predictive accuracy is needed before routine implementation in clinical laboratories.

Authors

Institutions

Publication Details

Journal
Microbiology Spectrum
Published
2026-11-17
DOI
https://doi.org/10.1128/spectrum.01345-26
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Rapid detection of beta-lactamase genes in Klebsiella pneumoniae and Escherichia coli from positive blood cultures using nanopore sequencing

Chalurmpon Srichomthong, Sira Sriswasdi, Voraphoj Nilaratanakul, Vorasuk Shotelersuk et al.
2 links
Microbiology Spectrum
Antibiotic Resistance in Bacteria
article

Rapid detection of beta-lactamase genes in Klebsiella pneumoniae and Escherichia coli from positive blood cultures using nanopore sequencing

Chalurmpon Srichomthong, Sira Sriswasdi, Voraphoj Nilaratanakul, Vorasuk Shotelersuk, Ploy N. Pratanwanich, Kornthara Kawang, Tanittha Chatsuwan, Napawan Punakabutra, Chanokkarn Chenphun, Thanutcha Posalee, Pornsawan Cholsaktrakool, Supakorn Maita, Tongsorn Prasertmanakit, Kraiwit Pollapong, Nantapong Pea-arun, Kamolpat Tangkijwanichkul
article en

Abstract

ABSTRACT Klebsiella pneumoniae and Escherichia coli are major Enterobacterales pathogens that commonly harbor beta-lactamase enzymes conferring antimicrobial resistance. Conventional antimicrobial susceptibility testing (AST) is time-consuming and may delay appropriate antibiotic treatment, whereas nanopore sequencing enables real-time genetic analysis and may support rapid antimicrobial resistance detection at the point of care. This study evaluated the performance of nanopore sequencing for detecting ceftriaxone and carbapenem resistance in positive blood cultures containing K. pneumoniae or E. coli . In this cross-sectional descriptive study, positive blood culture samples yielding K. pneumoniae or E. coli were analyzed. Bacterial DNA was extracted and sequenced in its native form using the PromethION nanopore platform to detect antimicrobial resistance genes, and sequencing-based predictions were compared with routine blood culture results and standard AST. A total of 62 K. pneumoniae and 96 E. coli samples met the inclusion criteria for DNA extraction and sequencing. Simulated real-time analysis showed that the optimal condition for detecting third-generation cephalosporin and carbapenem resistance genes was approximately 1 h of sequencing, using a sequence divergence threshold of <0.001 against the antimicrobial resistance gene database. For third-generation cephalosporin resistance, sensitivity was 87.0% (95% CI: 79.5%–94.5%) and specificity was 77.8% (95% CI: 68.7%–86.8%); for carbapenem resistance, sensitivity was 77.8% (95% CI: 58.6%–97.0%) and specificity was 96.4% (95% CI: 93.4%–99.5%). Overall, nanopore sequencing is feasible for rapid detection of ceftriaxone and carbapenem resistance directly from positive blood cultures, although further optimization is needed to improve accuracy. IMPORTANCE Bloodstream infections can progress rapidly and require timely selection of effective antimicrobial therapy. However, conventional antimicrobial susceptibility testing typically requires 2–3 days, which may delay optimal treatment. In this study, nanopore sequencing detected key antimicrobial resistance genes in Escherichia coli and Klebsiella pneumoniae directly from positive blood cultures after approximately 1 h of sequencing. This approach could support earlier prediction of antibiotic resistance and help guide more timely treatment decisions for patients with serious infections. The study also identified important limitations, including incorrect predictions for ceftriaxone and carbapenem resistance in some samples. Overall, these findings highlight the potential of rapid DNA sequencing to improve the management of bloodstream infections, while emphasizing that further improvement in predictive accuracy is needed before routine implementation in clinical laboratories.

Microbiology Spectrum
Burapha University (TH), Thai Red Cross Society (TH), Chulalongkorn University (TH), King Chulalongkorn Memorial Hospital (TH)
King Chulalongkorn Memorial Hospital, Chulalongkorn University, National Research Council of Thailand, Thailand Science Research and Innovation, Faculty of Medicine, Chulalongkorn University
Good health and well-being
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon